What Medefer does

Medefer (Medefer Ltd) is a UK-based digital health company founded in 2013 that operates a virtual outpatient platform connecting NHS patients with UK GMC-registered consultant specialists for remote triage and consultation. The platform enables patients referred through the NHS e-referral system — exercising their 'Right to Choose' — to receive consultant review within an average of 10–18 hours and triage within 48 hours in 99% of cases, with 71% of patients avoiding a physical outpatient appointment and 82% being discharged without a face-to-face visit. When in-person diagnostics or treatment are required, Medefer coordinates these through a UK-wide partner network including a GPhC-registered pharmacy partner (Dialachemist Ltd), blood test centres, and independent sector providers.

Medefer generates revenue through two primary channels. The first is NHS commissioning contracts with NHS trusts and Integrated Care Systems (BHRUT, Isle of Wight NHS Trust, James Paget University Hospital, Surrey and Sussex Cancer Alliance), where Medefer takes responsibility for full patient pathways including referral-to-treatment reporting and backlog recovery — these are managed-services arrangements with annual or multi-year terms. The second channel is direct-to-consumer private self-pay services with fixed pricing (Prostate Testing at £79, Weight Loss from £160, plus Menopause, Dermatology, and Sleep services), distributed via the company website.

The technology stack is workflow-oriented rather than AI-driven: a digital triage platform, a national consultant network spanning 18 specialties, secure data infrastructure compliant with CQC, ISO 9001/27001/14001, and Cyber Essentials Plus, and integrations with HubSpot, Qualtrics, Stripe, and standard analytics tools. The company is privately held, founded and led by Dr Bahman Nedjat as CEO, employs 101–250 staff, and has raised approximately $14.4M to date. NHS England cited Medefer as a model in its Online strategy and 10-year plan, aligning the company's roadmap with the 2027 NHS Online launch.

Name

Medefer

Legal name

Medefer Ltd

Website

https://medefer.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

Medefer is a UK digital health company operating a virtual outpatient platform that connects NHS patients with GMC-registered consultant specialists for remote triage and consultation, supported by NHS trust partnership contracts and a private self-pay service line covering prostate testing, menopause, dermatology, weight loss, and sleep.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. NHS Commissioned Services: Medefer provides NHS services under commissioning contracts with NHS trusts and Integrated Care Systems (ICS). Services are free at point of use for patients, with Medefer reimbursed by the NHS through contracted service agreements. The company manages patient pathways from referral through to treatment, including national RTT (Referral to Treatment) reporting.
2. Private Self-Pay Services: Direct-to-consumer private healthcare services including fixed-price treatments. Patients pay directly for consultations, diagnostic tests, and treatment packages. Examples include prostate testing (£79), menopause support, weight loss treatments (from £160), and skin treatments.
3. NHS Trust Partnership Agreements: Deep partnerships with NHS providers to transform outpatient services. Medefer takes full responsibility for patient pathways including new referrals and backlog recovery. Revenue derived from service contracts with NHS trusts such as BHRUT, Isle of Wight NHS Trust, and James Paget University Hospital.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Medefer operates a digital-first virtual outpatient platform connecting UK patients with GMC-registered NHS consultant specialists for remote triage, virtual consultations, and coordinated diagnostic pathways. It delivers free NHS-commissioned specialist care across 18 clinical specialties with a 48-hour consultant review promise, alongside fixed-price private self-pay services for menopause, prostate testing, dermatology, weight loss, and sleep problems. The company also partners with NHS trusts to transform outpatient services, manage backlogs, and meet RTT targets.

Product overview

Medefer operates a digital-first healthcare platform offering both free NHS specialist care services and private fixed-price services. The core offering is the NHS Specialist Care Service, enabling patients to receive consultant-led reviews within 48 hours through virtual consultations, supplemented by private services including Menopause Support, Prostate Testing (£79), Dermatology, Weight Loss (from £160), and Sleep Problems. The platform forms NHS partnerships to deliver virtual outpatient services across trusts (e.g., Isle of Wight, Barking Havering and Redbridge, James Paget), including specialty modules like Gastroenterology Virtual Hospital and the Targeted Prostate Health Check programme. A Knowledge Hub provides patient education content. The service connects patients with UK GMC-registered consultants, coordinates diagnostic testing through a UK-wide partner network, and provides access to in-house pharmacists.

Differentiator

Problem solved

Functional benefit

Products and services

• NHS Specialist Care Service Free NHS specialist care service enabling patients to receive consultant reviews within 48 hours via virtual consultations. Connects patients with UK GMC-registered NHS consultants remotely and coordinates in-person tests or treatment through a trusted partner network.
• Menopause Support Private fixed-price menopause treatment providing consultant-led care for menopause and perimenopausal symptoms, including hormone replacement therapy (HRT) consultations and testosterone gel treatments.
• Prostate Testing Private prostate health check priced at £79, offering at-home finger-prick PSA blood test kits processed in certified laboratories with consultant-led review and nurse support for results interpretation.
• Dermatology (Skin Problems) Private dermatology service providing teledermatology consultations for diagnosis and treatment of skin conditions including acne, eczema, psoriasis, and skin cancer, including diagnostic procedures such as skin biopsies, patch testing, and clinical photography.
• Weight Loss Private weight loss treatment service from £160 offering personalised weight management plans and treatments.
• Sleep Problems Private service for sleep problem consultations and treatment, providing access to specialist review within 48 hours.
• Gastroenterology Virtual Hospital Virtual outpatient service for NHS trusts managing gastroenterology appointments, enabling 99% of referrals to be triaged within 48 hours and 71% of patients to avoid physical outpatient appointments through virtual hospital pathways.
• Targeted Prostate Health Check (TPHC) Programme Case-finding programme in partnership with NHS Surrey and Sussex Cancer Alliance to identify at-risk men for prostate cancer screening via urine and PSA blood tests, with remote specialist oversight and rapid triage to hospitals for abnormal results.

Quantifiable outcome

• 99% of referrals triaged within 48 hours
• +6 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and flagship.

• The Prostate ProjectcoreStrategic or Co-development Partner · 26 March 2025Charity partnership for the Man Van mobile prostate screening initiative. Partnership delivered mobile PSA testing at Parliament (Speaker's Court, House of Commons) during Prostate Cancer Awareness Month 2025. The Prostate Project raises funds for the mobile unit, while Medefer provides clinical services and oversight.
• NHS Surrey and Sussex Cancer Alliance (SSCA)coreStrategic or Co-development Partner · 6 August 2022Talk Prostate partnership established in spring 2022 to identify 12,000 men (later expanded to 66,911) across Surrey and Sussex who might benefit from prostate cancer screening. Partnership addresses below-expected prostate cancer referrals during COVID-19 pandemic. Medefer provides remote specialist oversight and coordinated care pathways.
• Isle of Wight NHS TrustflagshipStrategic or Co-development Partner · 1 July 2020Virtual outpatient services partnership commissioned July 2020 as part of COVID-19 recovery programme. Managed over 3,000 patients waiting for outpatient attendance. Awarded 'Best Elective Care Recovery Initiative' in HSJ Partnership Awards 2022. Reduced RTT waiting times by 1% while national waiting times increased 40%.
• Barking, Havering and Redbridge University Trust (BHRUT)flagshipStrategic or Co-development Partner · 1 March 2017Partnership established March 2017 to build Gastroenterology Virtual Hospital for BHRUT outpatient services. Medefer manages outpatient appointments including support during COVID-19. Delivered exceptional outcomes: 99% referrals triaged within 48 hours, 71% patients avoided physical appointments, no waiting list for BHRUT gastro clinics during COVID-19.
• Dialachemist LtdcoreOthersDialachemist Ltd is an official partner of Medefer, providing registered pharmacy services. A registered pharmacist reviews patient records to ensure correct medication and issues prescriptions. GPhC Registration: 1106104. Based in the UK and compliant with all UK data protection laws.
• James Paget University Hospital (JPUH)coreStrategic or Co-development PartnerNHS trust partnership for outpatient transformation services. Case study partner showcasing Medefer's impact on reducing waiting times and improving patient care.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medefer
• LinkedInlinkedin.com/company/medefer

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds5 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medefer